Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials

Cancer Treatment Reviews

Volumn 30, Issue 4, 2004, Pages 359-368

  Sekine, Ikuo ^a   Yamamoto, Noboru ^a   Kunitoh, Hideo ^a   Ohe, Yuichiro ^a   Tamura, Tomohide ^a   Kodama, Tetsuro ^a   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemotherapy; Radiotherapy; Small cell lung cancer; The elderly

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; TENIPOSIDE; VINCRISTINE;

AGED; ANTINEOPLASTIC ACTIVITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG TOLERABILITY; ELDERLY CARE; ESOPHAGITIS; HEALTH STATUS; HUMAN; INFECTION; LEUKOPENIA; LUNG SMALL CELL CANCER; NEUTROPENIA; PATIENT SELECTION; POPULATION RESEARCH; REVIEW; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

EID: 2942626074     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2003.12.006     Document Type: Article

References (35)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
3. Murren J, Glatstein E, Pass HI. Small cell lung cancer. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 983-1018.
4. Stephens RJ, Johnson DH. Treatment and outcomes for elderly patients with small cell lung cancer. Drugs Aging 2000;17:229-47.
5. Shepherd FA, Bezjak A. Treatment of small cell lung cancer in the elderly patients. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, editors. Lung cancer: principles and practice. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 1081-91.
6. Sekine I, Fukuda H, Kunitoh H, Saijo N. Cancer chemotherapy in the elderly. Jon J Clin Oncol 1998;28:463-73.
7. American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997;15:2996-3018.
8. Nou E. Full chemotherapy in elderly patients with small cell bronchial carcinoma. Acta Oncol 1996;35:399-406.
9. Dajczman E, Fu LY, Small D, Wolkove N, Kreisman H. Treatment of small cell lung carcinoma in the elderly. Cancer 1996;77:2032-8.
10. Tebbutt NC, Snyder RD, Burns WI. An analysis of the outcomes of treatment of small cell lung cancer in the elderly. Aust N Z J Med 1997;27:160-4.
11. Jara C, Gomez-Aldaravi JL, Tirado R, et al. Small-cell lung cancer in the elderly - is age of patient a relevant factor? Acta Oncol 1999;38:781-6.
12. Oshita F, Kurata T, Kasai T, et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn J Cancer Res 1995;86:1198-202.
13. Goodwin JS, Hunt WC, Humble CG, Key CR, Samet JM. Cancer treatment protocols. Who gets chosen? Arch Intern Med 1988; 148:2258-60.
14. Paccagnella A, Favaretto A, Cipiani A, et al. Treatment of small cell lung cancer in elderly patients. Proc Am Soc Clin Oncol 1996;15:387 (abstract).
15. Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996;14:821-8.
16. Yuen AR, Zou G, Turrisi AT, et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 2000;89: 1953-60.
17. Girling DJ. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party. Lancet 1996; 348:563-6.
18. Souhami RL, Spiro SG, Rudd RM, et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst 1997;89:577-80.
19. Medical Research Council Lung Cancer Working Party. Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party. Br J Cancer 1996;73:406-13.
20. James LE, Gower NH, Rudd RM, et al. A randomised trial of low- dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer Research Campaign trial. Br J Cancer 1996;73: 1563-8.
21. Earl HM, Rudd RM, Spiro SG, et al. A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer 1991; 64:566-72.
22. Evans WK, Radwi A, Tomiak E, et al. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer. Am J Clin Oncol 1995;18:149-55.
23. Matsui K, Masuda N, Fukuoka M, et al. Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer. Br J Cancer 1998;77:1961-5.
24. Westeel V, Murray N, Gelmon K, et al. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 1998;16:1940-7.
25. Okamoto H, Watanabe K, Nishiwaki Y, et al. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol 1999;17:3540-5.
26. Samantas E, Skarlos DV, Pectasides D, et al. Combination chemotherapy with tow doses of weekly carboptatin and oral etoposide in poor risk small cell lung cancer. Lung Cancer 1999;23:159-68.
27. Pignon T, Gregor A, Schaake Koning C, et al. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998;46:239-48.
28. Westeel V, Murray N, Gelman K, et al. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 1998;16:1940-7.
29. Murray N, Grafton C, Shah A, et al. Abbreviated treatment for elderly, infirm, or noncompliant patients with timited-stage small-cell lung cancer. J Clin Oncol 1998;16:3323-8.
30. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study. Cancer 1998;82:836-41.
31. Noda K, Nishiwaki Y, Kawahara M, et al. Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
32. Yana T, Negoro S, Yokota M, Fukkuoka M. Phase II study of amrubicin (SM-5887), a 9-amino-anthracycline, in previously untreated patients with extensive stage small-cell lung cancer: a West Japan Lung Cancer Group Trial. Proc Am Soc Clin Oncol 1998;17:450a.
33. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-24.
34. Applegate WB, Blass JP, Williams TF. Instruments for the functional assessment of older patients. N Engl J Med 1990; 322:1207-14.
35. Stuch AE, Siu AL, Wieland GD, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993;342:1032-6.